Radiologists and the Defining Moment in the natural history of a disease process that change the management.

Radiologists and the Defining Moment in the natural history of a disease process that change the management.

Let's explore this concept organ by organ, focusing on common and impactful diseases where imaging is key to identifying these transitions. Please note that this list is not exhaustive.

1. Liver

Top 3 Diseases:

Cirrhosis and its complications
Hepatocellular Carcinoma (HCC)
Liver Metastases

Disease: Cirrhosis

Cirrhosis is a progressive process leading to fibrosis and architectural distortion of the liver. While the diagnosis itself is significant, several subsequent events are "defining moments" that dictate a drastic shift in management.

Defining Moment 1: Development of Ascites / Spontaneous Bacterial Peritonitis (SBP)
- Description: The transition from compensated to decompensated cirrhosis, often marked by fluid accumulation in the peritoneal cavity. SBP is an acute bacterial infection of this fluid, a life-threatening complication.
- Relevant Imaging Findings (CT/MRI):
  - Presence of peritoneal fluid, often diffuse.
  - Changes suggestive of SBP can be subtle: thickening and enhancement of bowel wall, peritoneum, and mesentery; loculated fluid collections; increased fluid density (less common on imaging, more a lab diagnosis).
  - Underlying signs of cirrhosis: Nodular liver contour, relative left lobe/caudate lobe hypertrophy, portosystemic collaterals, often splenomegaly.
- Advice to Radiologist:
  - Clearly report the presence and estimated volume of ascites.
  - Look specifically for imaging signs suggestive of peritonitis (bowel/peritoneal/mesenteric enhancement and thickening).
  - Mention associated findings like splenomegaly and collaterals as indicators of portal hypertension severity.
  - In the report impression, state "Findings consistent with decompensated cirrhosis with ascites" and note any signs suggestive of infection, prompting urgent clinical evaluation and paracentesis.
Defining Moment 2: Development of Portal Vein Thrombosis (PVT)
- Description: Clot formation within the portal vein or its branches. This further exacerbates portal hypertension and can impact candidacy for transplantation or other therapies. It can be bland or tumor-related (in the context of HCC).
- Relevant Imaging Findings (CT/MRI):
  - Filling defect within the portal vein lumen or its branches on contrast-enhanced imaging (arterial and portal venous phases are crucial).
  - Lack of flow signal on Doppler ultrasound (often the initial modality, but CT/MRI defines extent and nature).
  - Expansion of the affected vein lumen.
  - Development of periportal collateral vessels (cavernous transformation) in chronic PVT.
  - Assess if the thrombus enhances, raising suspicion for tumor thrombus (often related to HCC).
- Advice to Radiologist:
  - Identify and clearly describe the location and extent of the thrombus (main PV, branches, SMV/splenic vein involvement).
  - Evaluate the thrombus enhancement pattern on multiphase imaging to distinguish bland from tumor thrombus. This is CRITICAL for management.
  - Assess for associated cavernous transformation as a sign of chronicity.
  - State "Portal vein thrombosis identified" in the impression, specifying bland vs. suspicious for tumor thrombus, as this immediately changes management (anticoagulation vs. oncologic treatment planning).
Defining Moment 3: Development of Hepatocellular Carcinoma (HCC)
- Description: The occurrence of primary liver cancer, a frequent complication of cirrhosis ( $> 80%$ of cases). The presence of HCC changes management from monitoring/managing complications to cancer treatment (resection, ablation, chemoembolization, transplantation, systemic therapy).
- Relevant Imaging Findings (CT/MRI):
  - Focal liver lesion(s) with characteristic enhancement patterns on multiphase imaging: Arterial phase hyperenhancement (APHE) followed by washout in the portal venous or delayed phases, often with a capsule appearance. (These criteria are part of LI-RADS).
  - Lesion size and number are key (e.g., lesions $> 1$ cm in a cirrhotic liver are highly suspicious and require specific multiphase imaging).
  - Invasion of portal veins or hepatic veins (tumor thrombus).
  - Extrahepatic spread.
- Advice to Radiologist:
  - In any cirrhotic patient scan, meticulously evaluate for focal lesions.
  - Utilize appropriate multiphase technique (late arterial, portal venous, delayed) to characterize lesions according to established criteria (e.g., LI-RADS).
  - Assign a LI-RADS category (LR-1 to LR-5, LR-T, LR-M). LR-5 is diagnostic of HCC. LR-3 and LR-4 require follow-up or biopsy. LR-T suggests tumor thrombus. LR-M suggests malignancy but atypical for HCC.
  - Clearly report the size, number, location of any suspicious lesions, and presence/absence of vascular invasion or extrahepatic spread.
  - State the LI-RADS category in the impression. This directly guides subsequent clinical action (surveillance, biopsy, treatment planning).

2. Pancreas

Top 3 Diseases:

Acute Pancreatitis
Chronic Pancreatitis
Pancreatic Adenocarcinoma

Disease: Acute Pancreatitis

An inflammatory condition of the pancreas. While many cases are mild, the development of complications signifies a much more severe process requiring different interventions.

Defining Moment 1: Development of Necrosis
- Description: Non-viable pancreatic tissue or peripancreatic tissue. The extent of necrosis ( $< 30%$ , $30 - 50%$ , $> 50%$ ) is a major determinant of severity, risk of infection, and need for intervention.
- Relevant Imaging Findings (CT - preferred for necrosis assessment):
  - Areas of non-enhancing parenchyma on contrast-enhanced CT (performed $> 72$ hours after symptom onset for accurate assessment).
  - Absence of blood flow on color Doppler ultrasound (less reliable).
  - Location and extent of necrosis (pancreatic vs. peripancreatic, percentage involvement).
- Advice to Radiologist:
  - Use intravenous contrast and perform a delayed phase (pancreatic phase, ~40-50 seconds post-injection) for optimal necrosis assessment.
  - Quantify the approximate percentage of pancreatic parenchymal necrosis.
  - Describe the location and extent of any peripancreatic necrosis.
  - State "Necrotizing pancreatitis identified with estimated [X]% pancreatic necrosis" in the impression. This immediately risk-stratifies the patient and guides decisions regarding monitoring and potential intervention.
Defining Moment 2: Development of Fluid Collections / Pseudocysts / Walled-off Necrosis (WON)
- Description: Collections of fluid or necrotic material that form during or after pancreatitis. The terminology and management depend on timing and content (acute peripancreatic fluid collection, pseudocyst, acute necrotic collection, WON). Infected collections/WON are a critical "defining moment."
- Relevant Imaging Findings (CT/MRI):
  - Presence of fluid collections near the pancreas (acute peripancreatic fluid collection, APFC).
  - Well-defined, encapsulated fluid collection typically developing $> 4$ weeks after onset (pseudocyst).
  - Collections containing non-liquid components (necrotic debris) early on (acute necrotic collection, ANC) or $> 4$ weeks after onset with a well-defined wall (walled-off necrosis, WON).
  - Presence of gas within a collection is highly suggestive of infection (a critical defining moment within this category).
  - Assess size, location, and relationship to surrounding organs.
- Advice to Radiologist:
  - Accurately characterize the collection(s) based on timing and content using current terminology (APFC, pseudocyst, ANC, WON).
  - Look meticulously for gas within collections, as this is a strong indicator of infection requiring urgent drainage.
  - Report the size, location, and any signs of complications (e.g., mass effect on duodenum/bile duct, vascular involvement).
  - Clearly state the type of collection and any signs of infection in the impression. This guides decisions on conservative management vs. drainage (percutaneous, endoscopic, or surgical).
Defining Moment 3: Development of Vascular Complications (e.g., Splenic Vein Thrombosis, Pseudoaneurysm)

Description: Complications affecting adjacent vessels, such as clot formation in the splenic vein (leading to gastric varices) or formation of a pseudoaneurysm from arterial erosion (risk of life-threatening bleeding).
Relevant Imaging Findings (CT Angiography is often optimal):
- Splenic vein thrombosis: Filling defect in the splenic vein lumen on portal venous phase imaging. Assess for associated collateral vessels (gastric varices).
- Pseudoaneurysm: Focal outpouching of an artery (e.g., splenic, gastroduodenal) that fills with contrast on arterial phase and persists/enlarges on later phases. May be within a fluid collection/WON.
Advice to Radiologist:

Include arterial and portal venous phases in the CT protocol, especially if complications are suspected.
Actively trace peripancreatic vessels (splenic artery/vein, gastroduodenal artery, etc.) for signs of thrombosis or pseudoaneurysm.
If splenic vein thrombosis is found, specifically mention the presence and location of associated collaterals (e.g., gastric fundal varices).
The identification of a pseudoaneurysm is a surgical/interventional radiology EMERGENCY. State this finding CLEARLY and IMMEDIATELY communicate it to the clinical team.

Disease: Chronic Pancreatitis

A persistent inflammatory condition leading to irreversible damage, fibrosis, and loss of function. While chronic pain is a hallmark, the development of complications marks critical junctures requiring intervention.
- Defining Moment 1: Development of Symptomatic Pseudocysts Requiring Drainage
  - Description: Pseudocysts are encapsulated collections of pancreatic fluid, often following episodes of acute exacerbation or trauma in chronic pancreatitis. While many are asymptomatic, large or symptomatic pseudocysts (causing pain, obstruction of bile duct/duodenum, infection) require intervention.
  - Relevant Imaging Findings (CT/MRI):
    - Well-defined, often round or oval, fluid-density or T2 hyperintense collection with a discernible wall (usually taking $> 4$ weeks to mature).
    - Typically located near the pancreas, but can be distant.
    - Assess size, wall thickness/enhancement, and relationship to adjacent structures (bile duct, duodenum, stomach).
    - Look for internal septations or debris (less common in true pseudocysts vs. WON, but possible).
    - Presence of gas within the pseudocyst strongly suggests infection.
  - Advice to Radiologist:
    - Identify and characterize collections based on timing and imaging features to distinguish from acute collections or WON.
    - Report size, location, and relationship to adjacent organs.
    - Specifically look for signs of complications (mass effect, signs of infection like internal gas or enhancing wall).
    - State "Pancreatic pseudocyst identified, measuring [size]." Note if there are imaging features suggesting complications or infection, prompting drainage (endoscopic, percutaneous, or surgical).
- Defining Moment 2: Development of Major Pancreatic or Biliary Ductal Obstruction/Stricture
  - Description: Fibrosis or calcifications compressing or obstructing the main pancreatic duct or the intrapancreatic portion of the common bile duct. Pancreatic duct obstruction contributes to pain; biliary obstruction causes jaundice and increases risk of cholangitis. Requires drainage (endoscopic stenting, surgery).
  - Relevant Imaging Findings (CT/MRCP):
    - Dilation of the main pancreatic duct upstream from a stricture or obstructing calcification.
    - Dilation of the intra- and extrahepatic bile ducts down to the level of the pancreatic head.
    - Identifying the cause of the obstruction (stricture, calcification, mass).
    - MRCP is excellent for visualizing the ductal system.
  - Advice to Radiologist:
    - Carefully evaluate the pancreatic and bile ducts in patients with chronic pancreatitis.
    - Measure ductal diameters and identify the level and likely cause of obstruction.
    - State "Main pancreatic duct obstruction identified at [location] secondary to [cause, e.g., stricture/calcification]," or "Distal common bile duct obstruction identified due to changes of chronic pancreatitis." This guides the need for and approach to ductal decompression.
- Defining Moment 3: Suspicion or Development of Pancreatic Adenocarcinoma in a Chronic Pancreatitis Background
  - Description: Pancreatic cancer is a known complication of chronic pancreatitis, particularly hereditary or long-standing disease. Differentiating a benign inflammatory mass ("inflammatory head mass") from cancer is one of the most challenging diagnostic dilemmas in radiology, but vital as management is completely different. This suspicion is a critical defining moment requiring aggressive workup.
  - Relevant Imaging Findings (Multiphase CT/MRI):
    - Focal mass or ill-defined area of low enhancement (hypovascular) relative to the surrounding parenchyma (which may also be atrophic/fibrotic).
    - Abrupt cut-off of the main pancreatic duct or common bile duct (the "double duct" sign when both are dilated, though this can also be benign).
    - Atrophy of the pancreatic tail with dilation of the upstream duct, disproportionate to changes elsewhere (the "duct cut-off" sign).
    - Vascular encasement (SMA, celiac axis, SMV/PV) – a sign of unresectability, highly suggestive of malignancy.
    - Lymphadenopathy or distant metastases.
  - Advice to Radiologist:
    - Have a high index of suspicion for malignancy in chronic pancreatitis, especially with new or changing symptoms (weight loss, jaundice) or focal imaging findings.
    - Use optimal multiphase technique, particularly the pancreatic arterial and portal venous phases. Look for hypovascular masses.
    - Carefully evaluate the pancreatic and bile ducts for abrupt cut-offs.
    - Assess peripancreatic vessels for encasement.
    - State "Focal mass identified in the pancreatic head [or location] with features suspicious for adenocarcinoma in the setting of chronic pancreatitis." Clearly describe concerning features (hypovascularity, duct cut-off, vascular involvement). Recommend further workup (e.g., EUS with biopsy, repeat imaging). This is a crucial report that triggers an urgent oncologic evaluation pathway.
Disease: Pancreatic Adenocarcinoma
A highly aggressive malignancy. Staging on imaging is paramount, as it determines resectability and thus the primary treatment strategy.
- Defining Moment 1: Vascular Unresectability (Involvement of SMA, Celiac Axis, or SMV/PV Unreconstructibility)
  - Description: Tumor involvement of key peripancreatic arteries (Superior Mesenteric Artery, Celiac Axis) or veins (Superior Mesenteric Vein, Portal Vein) to an extent that precludes safe and complete surgical removal or venous reconstruction. This changes management from primary surgery to neoadjuvant therapy or palliative care.
  - Relevant Imaging Findings (Multiphase CT Angiography is key):
    - Encasement (>180 degrees) of the SMA or Celiac Axis by tumor.
    - Irreconstructible occlusion or encasement (>180 degrees) of the SMV-PV confluence.
    - Tumor extension into the root of the mesentery involving the SMA or first jejunal branch origin.
    - Loss of fat planes around these vessels.
  - Advice to Radiologist:
    - Perform a dedicated pancreatic protocol CT with thin cuts and arterial and portal venous phases for staging. Use MPR and volume rendering reconstructions to visualize vascular relationships.
    - Carefully assess the relationship of the tumor to the SMA, celiac axis, SMV, and portal vein.
    - Categorize the tumor based on vascular involvement according to established criteria (e.g., NCCN guidelines for resectable, borderline resectable, unresectable).
    - State the resectability status based on imaging findings (e.g., "Imaging findings consistent with unresectable pancreatic head adenocarcinoma due to SMA encasement"). This directly dictates whether the patient proceeds to surgery or alternative treatments.
- Defining Moment 2: Development of Distant Metastases
  - Description: Spread of cancer to sites outside the regional lymph nodes (most commonly liver, lungs, peritoneum). This indicates stage IV disease, which is generally not surgically curable and is managed with palliative systemic chemotherapy.
  - Relevant Imaging Findings (CT Chest/Abdomen/Pelvis):
    - Hypovascular lesions in the liver.
    - Lung nodules.
    - Malignant ascites or peritoneal implants/omental caking.
    - Enlarged lymph nodes distant from the primary tumor site.
  - Advice to Radiologist:
    - Perform comprehensive staging scans (CT CAP) for pancreatic adenocarcinoma.
    - Meticulously evaluate the liver, lungs, peritoneum, and lymph nodes.
    - Report the presence, location, and extent of any metastatic disease.
    - State "Distant metastases identified in [site(s)]" or "Peritoneal carcinomatosis present." This confirms stage IV disease and guides the shift to palliative systemic therapy.
- Defining Moment 3: Development of Biliary or Gastric Outlet Obstruction Requiring Palliation
  - Description: Tumor growth causing blockage of the distal common bile duct (leading to jaundice) or the duodenum (leading to vomiting and inability to eat). While not changing the curative potential, palliation of these symptoms (stenting, bypass surgery) significantly impacts quality of life and allows for systemic therapy.
  - Relevant Imaging Findings (CT/MRI):
    - Dilation of intra- and extrahepatic bile ducts secondary to a mass in the pancreatic head/uncinate process.
    - Gastric and/or duodenal dilation with a transition point at the level of the pancreatic mass.
  - Advice to Radiologist:
    - Identify the cause and level of any biliary or duodenal obstruction.
    - Measure the degree of upstream dilation.
    - State "Distal common bile duct obstruction identified due to pancreatic head mass," or "Duodenal obstruction identified by the pancreatic head mass." This prompts palliative intervention (ERCP for biliary stent, EUS-guided drainage, surgical bypass or stent for duodenal obstruction).

3. Kidneys

Top 3 Diseases:

Renal Cell Carcinoma (RCC)
Urinary Tract Obstruction (e.g., Urolithiasis, Stricture, Mass)
Pyelonephritis / Renal Abscess

Disease: Renal Cell Carcinoma (RCC)

The most common type of kidney cancer. Its management is heavily dictated by staging, particularly the presence of vascular invasion or metastatic disease.

Defining Moment 1: Invasion of Renal Vein or Inferior Vena Cava (IVC) Thrombus
- Description: Tumor extension into the renal vein and potentially into the IVC. This significantly impacts surgical approach (requires vascular expertise) and prognosis.
- Relevant Imaging Findings (CT/MRI - often multiphase with venous phase):
  - Filling defect within the renal vein lumen.
  - Tumor extension into the IVC, described by its superior extent (infrahepatic, intrahepatic, supradiaphragmatic).
  - The thrombus may enhance, confirming tumor thrombus.
- Advice to Radiologist:
  - Always evaluate the renal vein and IVC carefully when staging RCC. Include a dedicated venous phase.
  - Clearly report the presence and extent of venous tumor thrombus. Measurement of its superior extent within the IVC is crucial for surgical planning.
  - State "Renal vein and IVC tumor thrombus identified, extending to [level, e.g., infrahepatic IVC]." This finding necessitates a specialized surgical team.
Defining Moment 2: Development of Distant Metastases
- Description: Spread of RCC to distant sites (most commonly lung, bone, lymph nodes, liver, adrenal, brain). The presence of metastases changes the management from potentially curative surgery to systemic therapy, though cytoreductive nephrectomy may still be considered.
- Relevant Imaging Findings (CT Chest/Abdomen/Pelvis, sometimes Bone Scan, Brain MRI):
  - Nodules in the lungs (often peripheral).
  - Lytic or blastic bone lesions.
  - Enlarged lymph nodes outside the regional retroperitoneal basin.
  - Lesions in the liver, contralateral adrenal gland, brain, etc.
- Advice to Radiologist:
  - Perform comprehensive staging scans (typically CT CAP) for known or suspected RCC.
  - Meticulously search common metastatic sites.
  - Report any suspicious or confirmed metastatic lesions clearly, including size and location.
  - State "Distant metastases identified in [site(s)]." This finding is key to determining whether the patient is a candidate for curative surgery or palliative/systemic treatment.
Defining Moment 3: Invasion of Adjacent Organs / Gerota's Fascia (T3b/T4 staging)
- Description: Tumor extension beyond the kidney parenchyma into the perinephric fat, adrenal gland, or beyond Gerota's fascia. This impacts surgical resectability and local control.
- Relevant Imaging Findings (CT/MRI):
  - Stranding and/or nodularity extending from the tumor into the perinephric fat.
  - Direct invasion into the ipsilateral adrenal gland.
  - Extension through Gerota's fascia into adjacent structures (psoas muscle, posterior abdominal wall, colon, etc.).
- Advice to Radiologist:
  - Carefully assess the tumor margins and surrounding fat/fascia.
  - Look for infiltration or nodular extension outside the expected renal confines.
  - Report findings relevant to T staging (e.g., "Tumor extends into the perinephric fat but appears contained within Gerota's fascia," or "Tumor invades the ipsilateral adrenal gland"). This guides surgical planning and predicts potential for complete resection.

4. Gastrointestinal Tract (Focus on Colon & Small Bowel)

Top 3 Diseases:

Colorectal Cancer
Inflammatory Bowel Disease (IBD - Crohn's Disease)
Acute Diverticulitis

Disease: Colorectal Cancer

A common malignancy where imaging is vital for staging, assessing complications, and detecting recurrence.

Defining Moment 1: Development of Obstruction
- Description: Tumor growth causing significant narrowing or complete blockage of the bowel lumen. This requires urgent intervention (stenting, urgent surgery) to relieve the obstruction.
- Relevant Imaging Findings (CT Abdomen/Pelvis):
  - Dilated bowel loops proximal to the tumor.
  - Transition point at the tumor site with collapsed bowel distally.
  - Assess for signs of impending perforation (marked dilation, thinning wall, pneumatosis).
  - Identify the level and cause of obstruction.
- Advice to Radiologist:
  - If obstruction is present, clearly identify the level and likely cause (mass).
  - Measure the maximum diameter of the dilated bowel upstream.
  - Look for signs of compromise (pneumatosis, free air).
  - State "Large bowel obstruction identified, likely due to rectosigmoid mass," prompting urgent intervention.
Defining Moment 2: Development of Perforation
- Description: Tumor growth leading to a hole in the bowel wall, causing leakage of luminal contents into the peritoneal cavity (peritonitis) or retroperitoneum, a surgical emergency.
- Relevant Imaging Findings (CT Abdomen/Pelvis):
  - Extraluminal gas (free air in the peritoneum or retroperitoneum).
  - Loculated or diffuse fluid collections.
  - Thickening and enhancement of the peritoneum.
  - Discontinuity of the bowel wall at the tumor site (less often directly visible).
- Advice to Radiologist:
  - Actively look for free air, especially in non-dependent areas (anterior abdomen). Small amounts may be subtle.
  - Report the presence of free air and associated fluid/stranding.
  - State "Bowel perforation identified" in the impression. This requires immediate surgical consultation.
Defining Moment 3: Development of Distant Metastases / Peritoneal Carcinomatosis
- Description: Spread of cancer cells to distant organs (most commonly liver, lungs) or seeding of the peritoneal surface. This changes management to palliative or systemic therapy, potentially combined with surgery for complications or cytoreduction (like HIPEC for peritoneal disease).
- Relevant Imaging Findings (CT Chest/Abdomen/Pelvis, MRI Liver):
  - Hypovascular or hypervascular lesions in the liver depending on treatment history.
  - Lung nodules.
  - Enlarged lymph nodes outside the regional lymphatic drainage.
  - Peritoneal thickening, nodularity, omental caking, malignant ascites.
- Advice to Radiologist:
  - Perform comprehensive staging scans (CT CAP, sometimes MRI liver) for known colorectal cancer.
  - Meticulously evaluate the liver, lungs, lymph nodes, and peritoneal surfaces.
  - Describe the location and extent of any metastatic disease.
  - Clearly state "Distant metastases identified in [site(s)]" or "Peritoneal carcinomatosis present." This determines the systemic treatment plan and eligibility for certain surgical approaches.

Disease: Inflammatory Bowel Disease (Crohn's Disease Focus)

A chronic inflammatory condition that can affect any part of the GI tract. Complications often require surgical or endoscopic intervention.

Defining Moment 1: Development of Stricture
- Description: Chronic inflammation and fibrosis leading to narrowing of the bowel lumen. Can cause symptoms of partial or complete obstruction. Management depends on whether the stricture is predominantly inflammatory (potentially responsive to medical therapy) or fibrotic (requiring dilation or surgery).
- Relevant Imaging Findings (CT/MR Enterography):
  - Segmental luminal narrowing of a bowel loop.
  - Proximal bowel dilation upstream of the stricture.
  - Associated mural thickening (look at enhancement pattern - prominent enhancement suggests active inflammation, less enhancement suggests fibrosis).
  - Wall stratification (loss of stratification can suggest more chronic/fibrotic change).
- Advice to Radiologist:
  - Identify and report the location and length of strictures.
  - Assess signs of active inflammation vs. fibrosis based on mural enhancement, stratification, and surrounding edema/fat stranding.
  - Note the degree of proximal dilation.
  - State "Stricture identified in the [location] with pre-stenotic dilation," commenting on imaging features suggesting inflammatory vs. fibrotic etiology if possible, as this guides medical vs. interventional management.
Defining Moment 2: Development of Abscess
- Description: Collection of pus resulting from transmural inflammation and microperforation or frank perforation. Requires drainage (percutaneous or surgical) and antibiotics.
- Relevant Imaging Findings (CT Abdomen/Pelvis):
  - Loculated fluid collection with an enhancing rim, typically adjacent to a thickened bowel loop.
  - May contain gas bubbles.
  - Surrounding inflammatory stranding.
  - Often associated with phlegmonous inflammation.
- Advice to Radiologist:
  - Actively search for fluid collections in the mesentery or near affected bowel segments.
  - Describe the size, location, and characteristics of any abscess (enhancing rim, gas).
  - State "Abscess identified in the [location] adjacent to inflamed bowel." This prompts urgent drainage and antibiotic therapy.
Defining Moment 3: Development of Fistula
- Description: Abnormal tract connecting one loop of bowel to another structure (other bowel loop - entero-enteric, bladder - entero-vesical, skin - entero-cutaneous, etc.) resulting from transmural inflammation. Can lead to infection, malnutrition, or passage of contents into abnormal locations. Requires medical therapy or surgery.
- Relevant Imaging Findings (CT/MR Enterography, Barium Studies - less common now):
  - Visible tract filled with contrast (oral/rectal) or gas/fluid connecting two structures.
  - Thickened bowel walls at the points of connection.
  - Gas or fluid in an unexpected location (e.g., gas in the bladder with an entero-vesical fistula).
  - Associated inflammatory changes or abscesses.
- Advice to Radiologist:
  - Carefully follow thickened bowel loops to look for connecting tracts.
  - Evaluate adjacent organs (bladder, vagina, skin surface) for abnormal connections.
  - If a fistula is identified, clearly state the structures it connects (e.g., "Entero-vesical fistula demonstrated between the sigmoid colon and bladder"). This finding guides specific surgical planning.

5. Gallbladder and Biliary Tract

Top 3 Diseases:

Acute Cholecystitis and its complications
Choledocholithiasis / Ascending Cholangitis
Gallbladder Cancer

Disease: Acute Cholecystitis

Inflammation of the gallbladder, usually due to cystic duct obstruction by a gallstone. Complications are surgical emergencies.

Defining Moment 1: Development of Gangrene / Perforation
- Description: Severe inflammation leading to necrosis of the gallbladder wall (gangrene) and potentially rupture (perforation), resulting in peritonitis (generalized or localized abscess). A life-threatening surgical emergency.
- Relevant Imaging Findings (CT/Ultrasound - CT is better for complications):
  - CT: Irregular or absent gallbladder wall enhancement, intraluminal gas (emphysematous cholecystitis - specific, severe form), pericholecystic fluid extending beyond the gallbladder fossa, focal wall defect, gallstones outside the lumen, free fluid/abscess collection.
  - Ultrasound: Absence of flow in the gallbladder wall on Doppler, striations within the wall, pericholecystic fluid, focal wall defect.
- Advice to Radiologist:
  - In suspected acute cholecystitis, look specifically for signs of gangrene or perforation.
  - Report the presence of wall irregularity, lack of enhancement, intraluminal gas, and extent of pericholecystic fluid or abscess.
  - State "Findings suspicious for gallbladder gangrene or perforation" or "Emphysematous cholecystitis identified." This requires immediate surgical intervention.
Defining Moment 2: Development of Pericholecystic Abscess
- Description: A localized collection of pus around the gallbladder, often contained by adhesions, following microperforation. Requires drainage.
- Relevant Imaging Findings (CT):
  - Loculated fluid collection with an enhancing rim adjacent to the inflamed gallbladder.
  - May contain gas.
- Advice to Radiologist:
- Disease: Acute Cholecystitis and its complications (Continued)
  - Role of Biliary Anatomy & Defining Moment: Mirizzi Syndrome
    - Description: A complication where a gallstone impacted in the cystic duct or gallbladder neck compresses the common hepatic duct or common bile duct extrinsically, or erodes into it, causing biliary obstruction. This changes the surgical approach from a standard cholecystectomy to a more complex procedure due to inflammation and altered anatomy at the porta hepatis.
    - Relevant Imaging Findings (Ultrasound, CT, MRCP):
      - Stone impacted in the cystic duct or gallbladder neck.
      - Extrinsic compression and narrowing of the adjacent common hepatic duct (CHD) or CBD.
      - Dilation of the biliary tree proximal to the compression.
      - Potential fistula formation between the gallbladder and the CHD/CBD (may require contrast studies or MRCP to visualize clearly).
      - Imaging findings of acute cholecystitis may also be present.
    - Advice to Radiologist:
      - In patients with right upper quadrant pain, jaundice, and suspected cholecystitis, carefully evaluate the cystic duct and gallbladder neck for impacted stones and their relationship to the CHD/CBD.
      - Look for extrinsic compression or signs of fistula.
      - Measure biliary duct dilation proximal to the compression.
      - State "Imaging findings consistent with Mirizzi Syndrome (Type [if type can be determined]) secondary to impacted cystic duct stone causing extrinsic compression of the common hepatic duct." Identifying this pre-operatively is crucial for the surgical team to anticipate a difficult dissection and potential need for biliary reconstruction.

Disease: Choledocholithiasis / Ascending Cholangitis

Stones in the common bile duct (CBD) causing obstruction, which can lead to bacterial infection of the bile (cholangitis) and sepsis.

Defining Moment 1: Biliary Obstruction Level and Cause Leading to Cholangitis
- Description: Obstruction of the CBD causing biliary dilation and stasis, leading to bacterial overgrowth and infection spreading up the biliary tree. Severity of cholangitis can vary; severe cholangitis is a life-threatening emergency.
- Relevant Imaging Findings (Ultrasound, CT, MRI/MRCP):
  - Dilated intrahepatic and extrahepatic bile ducts ( $> 6 - 8$ mm CBD diameter, accounting for age/post-cholecystectomy).
  - Identifying the cause of obstruction (stone, stricture, mass) and its level in the CBD.
  - Signs of infection: Bile duct wall thickening and enhancement on contrast CT/MRI, periductal stranding, liver abscesses (severe cholangitis).
  - Ultrasound is often initial, but CT/MRCP better define level/cause of obstruction and complications.
- Advice to Radiologist:
  - Measure bile duct diameters and report the level of dilation.
  - Actively search for the cause of obstruction in the CBD/ampulla.
  - Look for imaging signs of cholangitis (wall thickening/enhancement, periductal changes).
  - If signs of severe infection (abscesses) or high-grade obstruction are present, state this clearly.
  - State "Biliary obstruction identified at the level of [location, e.g., distal CBD], likely secondary to [cause, e.g., stone]. Findings suggestive of associated cholangitis." This necessitates urgent biliary decompression (ERCP, PTC, surgery).

Abdominal radiology resource for resident radiologist

Search This Blog